Sánchez-Reyes L, Fanghänel G, Márquez-Cid ME, Salazar RR, Labastida-Sánchez C, Solís-Pérez A, Tusie LMT

Idioma: Español
Referencias bibliográficas: 36
Paginas: 5-11
Archivo PDF: 63.03 Kb.

RESUMEN

La diabetes de comportamiento del adulto que se presenta en el joven, denominada como MODY por sus siglas en inglés, es un subtipo heterogéneo de diabetes mellitus tipo 2 que se presenta por una alteración genética, caracterizada por un carácter autosómico dominante inherente y primario a un defecto en la secreción de insulina. En el presente artículo revisamos las bases fisiopatológicas de los distintos tipos de MODY y se describen las manifestaciones clínicas así como su diagnóstico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Expert Committee on the Diagnosis and Classification ofDiabetes Mellitus: Report of the Expert Committee on theDiagnosis and Classification of Diabetes Mellitus. DiabetesCare 2000; 23 (Suppl.1): S4-S19.

2. Tattersall RB, Fajans SS. A difference between theinheritance of classical juvenile-onset and maturity-onsettype diabetes of young people. Diabetes 1975; 24: 44.

3. Doria A, Plengvidya N. Recent advances in the genetics ofmaturity-onset diabetes of the young and other forms ofautosomal dominant diabetes. Curr Opin Endo Diab 2000;7: 203.

4. Wang H, Maechler P, Antinozzi PA, Kerstin A, HagenfeldtKA, Wollheim CB. Hepatocyte Nuclear Factor 4 Regulatesthe Expression of Pancreatic-Cell Genes Implicated inGlucose Metabolism and Nutrient-induced Insulin Secretion.J Biol Chem 2000; 275: 35953.

5. Velho G, Froguel P. Genetic, metabolic and clinicalcharacteristics of maturity onset diabetes of the young.Eur J Endocrinol 1998; 138(3): 233.

6. Lindner T, Gragnoli C, Furuta H, Cockburn BN, Petzold C,Rietzsch H et al. Hepatic function in a family with a nonsensemutation (R154X) in the hepatocyte nuclear factor-4 alpha/MODY1 gene. J Clin Invest 1997; 100: 1400-1405.

7. Shih DQ, Dansky HM, Flaisher M, Assmann G, Fajans SS,Stoffel M. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated withreduced apolipoprotein (AII), apolipoprotein (CIII),lipoprotein (a) and triglyceride levels. Diabetes 2000; 49: 832-837.

8. Bogan AA, Dallas-Yang Q, Ruse MD, Maeda Y, Jiang G,Nepomuceno L et al. Analysis of protein dimerization andligand binding of orphan receptor HNF-4alpha. J Mol Biol2000; 302: 831-851.

9. Stoffel M, Duncan SA. The maturity onset diabetes of theyoung (MODY1) transcription factor HNF-4alpha regulatesexpression of genes required for glucose transport andmetabolism. Proc Natl Acad Sci USA 1997; 594(24): 13209.

10. Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y,Yamagata K et al. Organization and partial sequence ofthe hepatocyte nuclear factor-4 alpha/MODY1 gene andidentification of a missense mutation, R127W, in aJapanese family with MODY. Diabetes 1997; 46: 1652-7.

11. Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M,Lingott A et al. Naturally occurring mutations in the humanHNF-4alpha gene impair the function of the transcriptionfactor to a varying degree. Nucleic Acids Res 2000; 28:430-437.

12. Froguel P, Vaxillaire M. Close linkage of glucokinase locuson chromosome 7p to early-oset non-insulin-dependent diabetesmellitus. Nature 1992; 356: 162-164.

13. Stoffel M, Froguel P, Takeda J, Zouali H, Vionnet N, Nishi S etal. Identification of glucokinase mutations in subjects withgestational diabetes mellitus. Diabetes 1993; 42: 937-940.

14. Grupe A, Hultgren B. Transgenic knockouts reveal a criticalrequirement for pancreatic beta cell glucokinase inmaintaining glucose homeostasis. Cell 1995; 83: 69-78.

15. Hattersley AT, Beards F. Mutations in the glucokinase geneof the fetus result in reduced birth weight. Nat Genet 1998;19: 268-70.

16. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB.Dominant-negative supression of HNF-1 alfa function resultsin defective insulin gene transcription and impairedmetabolism-secretion coupling in a pancreatic beta-cell line.EMBO J 1998; 17: 6701-6713.

17. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, VaxillaireM et al. Mutations in the hepatocyte nuclear factor-1 alphagen in maturity-onset diabetes of the young. Nature 1996;384: 455-458.

18. Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyawa J,Okita K et al. Mutation P291fsinsC in the transcription factorhepatocyte nuclear factor-1 alpha is dominant negative.Diabetes 1998; 47: 1231-1235.

19. Frayling TM, Bulman MP, Ellard S. Mutations in the hepatocytenuclear factor-1alpha gene are a common cause of maturityonsetof the young in the UK. Diabetes 1997; 46: 720.

20. Hansen T, Eiberg H, Rovard M, Vaxillaire M, Moller ES,Ramussen SK et al. Novel MODY3 mutations in thehepatocyte nuclear-1alpha. Diabetes 1997; 46: 726-730.

21. Glucksman MA, Lehto M, Tayber O. Novel mutations and amutational hotspot in the MODY3 gene. Diabetes 1997;46: 1081.

22. Lesage S, Hani EH, Philippi A. Linkage analysis of theMODY3 locus on chromosome 12q with late-onset NIDDM.Diabetes 1995; 44: 1243.

23. Urhammer SA, Fridberg M, Hansen T, Rasmussen SK, MollerES, Clausen JO et al. A prevalent aminoacid polymorphismat codon 98 in the hepatocyte nuclear factor-1alpha geneis associated with reduced serum C-peptide and insulinresponses to an oral glucose challenge. Diabetes 1997;46: 912-916.

24. Urhammer SA. The Ala/Val98 polymorphism of the hepatocytenuclear factor-1alpha gene contributes to the interindividualvariation in serum C-peptide response during an oral glucosetolerance test: evidence from studies of 231 glucose-tolerantfirst degree relatives of type 2 diabetes probands. J ClinEndocrinol Metab 1998; 83: 4506-4509.

25. Mezel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, MezelS. A low renal threshold for glucose in diabetic patients witha mutation in the hepatocyte nuclear factor-l alpha (HNF-1alpha) gene. Diabet Med 1998; 15: 816-820.

26. Pearson ER, Liddell WG, Shepherd M, Corrall RJ, HotterleyAT. Sensivity to sulphonilureas in patients with hepatocytenuclear factor-1alpha gene mutations: evidencefor pharmacogenetics in diabetes. Diabet Med 2000;17: 543-545.

27. Stoffers DA, Zinkin NT, Stanojevic V. Pancreatic agenesisattributable to a single nucleotide deletion in the human IPF1gene coding sequence. Nat Genet 1997; 15: Abstact 106.

28. Stoffers DA, Ferrer J, Clarke WL. Early-onset type II diabetesmellitus (MODY4) linked to IPF1. Nat Genet 1997; 17: 138.

29. Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, HonikawaY. Frameshift mutation, A263fsinsGG, in hepatocyte nuclearfactor-1beta gene associated with diabetes and renaldysfunction. Diabetes 1998; 47: 1354-1355.

30. Iwasaki N, Ogata M, Tomonaga O, Kuroki H, Kasahara T,Yano N et al. Liver and kidney function in Japanese patientswith maturity-onset diabetes of the young. Diabetes Care1998; 21: 2144-2148.

31. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T.Mutations in NEUROD1 are associated with the developmentof type 2 diabetes mellitus. Nat Get 1999: 323.

32. Moller AM, Ek J, Durviaux SM, Urhammer SA, Clausen JO,Eiberg H et al. Hepatocyte nuclear factor-6: associationsbetween genetic variability and type II diabetes andbetween genetic variability and estimates of insulinsecretion. Diabetología 1999; 42: 1011-1016.

33. Zhu Q, Yamagata K, Yu L, Tomura H, Yamada S, Yang Q et al.Identification of missense mutations in the hepatocyte nuclearfactor 3beta gene in Japanese subjects with late-oncettype II diabetes mellitus.Diabetología 2000; 43: 1197-1200.

34. Hattersley A. Identifying genes for disease. Summer School2000; 10-14 July 2000, Bristol Maniot Hotel, Bristol, UK.

35. Permutt MA, Hattersley A. Searching for Type 2 diabetesGenes in the Post-genoma era. Trends Endocrinol Metab2000; 11: 383-393.

36. Tusié LMT. La genética de la diabetes mellitus tipo 2: genesimplicados en la diabetes de aparición temprana. Revistade Investigación Clínica 2000; 52(3): 296-305.